Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Neuroendocrine activation is known to occur in patients with congestive heart failure, but there is uncertainty as to whether this occurs before or after the presence of overt symptoms. In the Studies of Left Ventricular Dysfunction (SOLVD), a multicenter study of patients with ejection fractions of 35% or less, we compared baseline plasma norepinephrine, plasma renin activity, plasma atrial natriuretic factor, and plasma arginine vasopressin in 56 control subjects, 151 patients with left ventricular dysfunction (no overt heart failure), and 81 patients with overt heart failure before randomization. Median values for plasma norepinephrine (p = 0.0001), plasma atrial natriuretic factor (p less than 0.0001), plasma arginine vasopressin (p = 0.006), and plasma renin activity (p = 0.03) were significantly higher in patients with left ventricular dysfunction than in normal control subjects. Neuroendocrine values were highest in patients with overt heart failure. Plasma renin activity was normal in patients with left ventricular dysfunction without heart failure who were not receiving diuretics and was significantly increased (p less than 0.05) in patients on diuretic therapy. We conclude that neuroendocrine activation occurs in patients with left ventricular dysfunction and no heart failure. Neuroendocrine activation is further increased as overt heart failure ensues and diuretics are added to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Self-citationEffect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & Braunwald, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,103
The Neurohumoral Axis in Congestive Heart Failure
FRANCIS, G. S., GOLDSMITH, S. R., LEVINE, T. B., OLIVARI, M. T., & COHN, J. N. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-370 · Cited by 600
Self-citationFRANCIS, G. S., SIEGEL, R. M., GOLDSMITH, S. R., OLIVARI, M. T., LEVINE, T. B., & COHN, J. N. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-1-1 · Cited by 579
Self-citationUntreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
Bayliss, J., Norell, M., Canepa-Anson, R., Sutton, G., & Poole-Wilson, P. (1987) · Heart · doi:10.1136/hrt.57.1.17 · Cited by 509
TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
Sharpe, N., Smith, H., Murphy, J., & Hannan, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90347-9 · Cited by 481
Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure
Gottlieb, S. S., Kukin, M. L., Ahern, D., & Packer, M. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90344-6 · Cited by 354
Riegger, G. A. J., Liebau, G., Holzschuh, M., Witkowski, D., Steilner, H., & KOCHSIEK, K. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90040-7 · Cited by 90
Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure
Pfeffer, J. M., & Pfeffer, M. A. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90203-3 · Cited by 87
Kubo, S. H., Clark, M., Laragh, J. H., BORER, J. S., & Cody, R. J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90615-1 · Cited by 85
Self-citation
Cited by
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161
Konstam, M. A. (2007) · JAMA · doi:10.1001/jama.297.12.1319 · Cited by 1,628
Guidelines for the diagnosis and treatment of chronic heart failure
Remme, W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2783 · Cited by 1,592
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,527
Kobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
Hormones and Hemodynamics in Heart Failure
Schrier, R. W., & Abraham, W. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410806 · Cited by 1,199
Costanzo, M. R., Guglin, M. E., Saltzberg, M. T., Jessup, M. L., Bart, B. A., Teerlink, J. R., Jaski, B. E., Fang, J. C., Feller, E. D., Haas, G. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.073 · Cited by 1,117
Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure
Hillege, H. L., Girbes, A. R. J., de Kam, P. J., Boomsma, F., de Zeeuw, D., Charlesworth, A., Hampton, J. R., & van Veldhuisen, D. J. (2000) · Circulation · doi:10.1161/01.cir.102.2.203 · Cited by 1,045
The epidemiology of heart failure
Cowie, M. R., Mosterd, A., Wood, D. A., Deckers, J. W., Poole-Wilson, P. A., Sutton, G. C., & Grobbee, D. E. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015223 · Cited by 1,018
Biochemical detection of left-ventricular systolic dysfunction
McDonagh, T., Robb, S., Murdoch, D., Morton, J., Ford, I., Morrison, C., Tunstall-Pedoe, H., McMurray, J., & Dargie, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03034-1 · Cited by 963
Kitzman, D. W. (2002) · JAMA · doi:10.1001/jama.288.17.2144 · Cited by 883
Cowie, M. R., Struthers, A. D., Wood, D. A., Coats, A. J., Thompson, S. G., Poole-Wilson, P. A., & Sutton, G. C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06031-5 · Cited by 872
Mancini, D. M., Walter, G., Reichek, N., Lenkinski, R., McCully, K. K., Mullen, J. L., & Wilson, J. R. (1992) · Circulation · doi:10.1161/01.cir.85.4.1364 · Cited by 735
Neurohormonal activation in heart failure with reduced ejection fraction
Hartupee, J., & Mann, D. L. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.163 · Cited by 709
McKelvie, R. S., Yusuf, S., Pericak, D., Avezum, A., Burns, R. J., Probstfield, J., Tsuyuki, R. T., White, M., Rouleau, J., Latini, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.10.1056 · Cited by 692
Self-citationDi Salvo, T. G., Mathier, M., Semigran, M. J., & Dec, G. W. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00511-n · Cited by 685
Cheng, V., Kazanagra, R., Garcia, A., Lenert, L., Krishnaswamy, P., Gardetto, N., Clopton, P., & Maisel, A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01157-8 · Cited by 668
Gheorghiade, M. (2004) · JAMA · doi:10.1001/jama.291.16.1963 · Cited by 651
Richards, A. M., Nicholls, M. G., Yandle, T. G., Frampton, C., Espiner, E. A., Turner, J. G., Buttimore, R. C., Lainchbury, J. G., Elliott, J. M., Ikram, H., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1921 · Cited by 646
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
Colucci, W. S., Packer, M., Bristow, M. R., Gilbert, E. M., Cohn, J. N., Fowler, M. B., Krueger, S. K., Hershberger, R., Uretsky, B. F., Bowers, J. A., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2800 · Cited by 635
Frantz, S., Hundertmark, M. J., Schulz-Menger, J., Bengel, F. M., & Bauersachs, J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac223 · Cited by 606
Chow, S. L., Maisel, A. S., Anand, I., Bozkurt, B., de Boer, R. A., Felker, G. M., Fonarow, G. C., Greenberg, B., Januzzi, J. L., Kiernan, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000490 · Cited by 601
Narula, J., Pandey, P., Arbustini, E., Haider, N., Narula, N., Kolodgie, F. D., Dal Bello, B., Semigran, M. J., Bielsa-Masdeu, A., Dec, G. W., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8144 · Cited by 585
Aldosterone-Induced Inflammation in the Rat Heart
Sun, Y., Zhang, J., Lu, L., Chen, S. S., Quinn, M. T., & Weber, K. T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64454-9 · Cited by 567
Extracellular Matrix Remodeling in Heart Failure: A Role for De Novo Angiotensin II Generation
Weber, K. T. (1997) · Circulation · doi:10.1161/01.cir.96.11.4065 · Cited by 557
Yamamoto, K., Burnett, J. C., Jougasaki, M., Nishimura, R. A., Bailey, K. R., Saito, Y., Nakao, K., & Redfield, M. M. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.988 · Cited by 524
O'Connor, C. M., Gattis, W. A., Uretsky, B. F., Adams, K. F., McNulty, S. E., Grossman, S. H., McKenna, W. J., Zannad, F., Swedberg, K., Gheorghiade, M., et al. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70250-4 · Cited by 517
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Lonn, E. M., Yusuf, S., Jha, P., Montague, T. J., Teo, K. K., Benedict, C. R., & Pitt, B. (1994) · Circulation · doi:10.1161/01.cir.90.4.2056 · Cited by 503
Self-citationGreenberg, B., Quinones, M. A., Koilpillai, C., Limacher, M., Shindler, D., Benedict, C., & Shelton, B. (1995) · Circulation · doi:10.1161/01.cir.91.10.2573 · Cited by 473
Self-citationPathophysiology of chronic heart failure
Packer, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90405-r · Cited by 473
Ahmed, A., Husain, A., Love, T. E., Gambassi, G., Dell'Italia, L. J., Francis, G. S., Gheorghiade, M., Allman, R. M., Meleth, S., & Bourge, R. C. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi890 · Cited by 467
Self-citationAnimal models of human cardiovascular disease, heart failure and hypertrophy
Hasenfuss, G. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00110-2 · Cited by 441
B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
Richards, A. M., Nicholls, M. G., Espiner, E. A., Lainchbury, J. G., Troughton, R. W., Elliott, J., Frampton, C., Turner, J., Crozier, I. G., & Yandle, T. G. (2003) · Circulation · doi:10.1161/01.cir.0000070953.76250.b9 · Cited by 436
Kazanegra, R., Cheng, V., Garcia, A., Krishnaswamy, P., Gardetto, N., Clopton, P., & Maisel, A. (2001) · Journal of Cardiac Failure · doi:10.1054/jcaf.2001.23355 · Cited by 434
The renin-angiotensin-aldosterone system and its suppression
Ames, M. K., Atkins, C. E., & Pitt, B. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15454 · Cited by 433
Sympathetic Activation and Loss of Reflex Sympathetic Control in Mild Congestive Heart Failure
Grassi, G., Seravalle, G., Cattaneo, B. M., Lanfranchi, A., Vailati, S., Giannattasio, C., Del Bo, A., Sala, C., Bolla, G. B., Pozzi, M., et al. (1995) · Circulation · doi:10.1161/01.cir.92.11.3206 · Cited by 432
Doughty, R. N., Whalley, G. A., Gamble, G., MacMahon, S., & Sharpe, N. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00012-0 · Cited by 422
Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects
Griffin, M., Rao, V. S., Ivey-Miranda, J., Fleming, J., Mahoney, D., Maulion, C., Suda, N., Siwakoti, K., Ahmad, T., Jacoby, D., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.045691 · Cited by 414
Relation of Loop Diuretic Dose to Mortality in Advanced Heart Failure
Eshaghian, S., Horwich, T. B., & Fonarow, G. C. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.072 · Cited by 410
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin
Richards, A. M., Doughty, R., Nicholls, M. G., MacMahon, S., Sharpe, N., Murphy, J., Espiner, E. A., Frampton, C., & Yandle, T. G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01269-4 · Cited by 389
Cohn, J. N., Pfeffer, M. A., Rouleau, J., Sharpe, N., Swedberg, K., Straub, M., Wiltse, C., Wright, T. J., & for the MOXCON Investigators (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00163-6 · Cited by 384
Maisel, A. S., Koon, J., Krishnaswamy, P., Kazenegra, R., Clopton, P., Gardetto, N., Morrisey, R., Garcia, A., Chiu, A., & De Maria, A. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113215 · Cited by 381
Mitochondrial oxidative stress and dysfunction in myocardial remodelling
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn280 · Cited by 377
Diuretic resistance predicts mortality in patients with advanced heart failure
Neuberg, G. W., Miller, A. B., O'Connor, C. M., Belkin, R. N., Carson, P. E., Cropp, A. B., Frid, D. J., Nye, R. G., Pressler, M. L., Wertheimer, J. H., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.123144 · Cited by 372
Udelson, J. E., Smith, W. B., Hendrix, G. H., Painchaud, C. A., Ghazzi, M., Thomas, I., Ghali, J. K., Selaru, P., Chanoine, F., Pressler, M. L., et al. (2001) · Circulation · doi:10.1161/hc4501.099313 · Cited by 362
Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure
Floras, J. S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90466-e · Cited by 361
Benedict, C. R., Shelton, B., Johnstone, D. E., Francis, G., Greenberg, B., Konstam, M., Probstfield, J. L., & Yusuf, S. (1996) · Circulation · doi:10.1161/01.cir.94.4.690 · Cited by 353
Self-citationAronson, D., Mittleman, M. A., & Burger, A. J. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.11.014 · Cited by 346
The effects of exercise training on sympathetic neural activation in advanced heart failure
Roveda, F., Middlekauff, H. R., Rondon, M. U. P. B., Reis, S. F., Souza, M., Nastari, L., Barretto, A. C. P., Krieger, E. M., & Negrão, C. E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00831-3 · Cited by 334
(2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.003 · Cited by 331
Acute Hemodynamic Improvement by Thermal Vasodilation in Congestive Heart Failure
Tei, C., Horikiri, Y., Park, J.-C., Jeong, J.-W., Chang, K.-S., Toyama, Y., & Tanaka, N. (1995) · Circulation · doi:10.1161/01.cir.91.10.2582 · Cited by 324
Increased muscle sympathetic nerve activity predicts mortality in heart failure patients
Barretto, A. C. P., Santos, A. C., Munhoz, R., Rondon, M. U. P. B., Franco, F. G., Trombetta, I. C., Roveda, F., de Matos, L. N. J., Braga, A. M. W., Middlekauff, H. R., et al. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.03.056 · Cited by 324
β-Blocker Therapy in Heart Failure: Scientific Review
Foody, J. M., Farrell, M. H., & Krumholz, H. M. (2002) · JAMA · doi:10.1001/jama.287.7.883 · Cited by 322
Lerman, A., Gibbons, R. J., Rodeheffer, R. J., Bailey, K. R., McKinley, L. J., Heublein, D. M., & Burnett, J. C. (1993) · The Lancet · doi:10.1016/0140-6736(93)93125-k · Cited by 318
Konstam, M. A., Kronenberg, M. W., Rousseau, M. F., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S., & Kinan, D. (1993) · Circulation · doi:10.1161/01.cir.88.5.2277 · Cited by 316
“At Tufts University and at Vanderbilt University, radionuclide studies were performed at three additional time points: (1) 4 months after randomization; (2) at the completion of SOLVD, 13 to 45 months (mean, 25) after randomization while patients continued to receive study drug; (3) after withdrawal of study drug for…”
MethodPhysician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure
Ritzema, J., Troughton, R., Melton, I., Crozier, I., Doughty, R., Krum, H., Walton, A., Adamson, P., Kar, S., Shah, P. K., et al. (2010) · Circulation · doi:10.1161/circulationaha.108.800490 · Cited by 316
Eichhorn, E. J., Heesch, C. M., Barnett, J. H., Alvarez, L. G., Fass, S. M., Grayburn, P. A., Hatfield, B. A., Marcoux, L. G., & Malloy, C. R. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90114-7 · Cited by 306
Volpe, M., Carnovali, M., & Mastromarino, V. (2015) · Clinical Science · doi:10.1042/cs20150469 · Cited by 305
Hartmann, F., Packer, M., Coats, A. J. S., Fowler, M. B., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Anker, S. D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143059.68996.a7 · Cited by 301
Testani, J. M., Brisco, M. A., Turner, J. M., Spatz, E. S., Bellumkonda, L., Parikh, C. R., & Tang, W. H. W. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000895 · Cited by 296
Loop Diuretics in Acute Decompensated Heart Failure: Necessary? Evil? A Necessary Evil?
Felker, G. M., O'Connor, C. M., & Braunwald, E. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.821785 · Cited by 296
Latini, R., Masson, S., Anand, I., Judd, D., Maggioni, A. P., Chiang, Y.-T., Bevilacqua, M., Salio, M., Cardano, P., Dunselman, P. H. J. M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000036747.68104.ac · Cited by 291
Kaye, D. M., Lambert, G. W., Lefkovits, J., Morris, M., Jennings, G., & Esler, M. D. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90738-2 · Cited by 286
Rouleau, J.-L., Packer, M., Moyé, L., de Champlain, J., Bichet, D., Klein, M., Rouleau, J. R., Sussex, B., Arnold, J. M., Sestier, F., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90001-9 · Cited by 285
Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure
Weinfeld, M. S., Chertow, G. M., & Stevenson, L. W. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70113-4 · Cited by 278
Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure
Chua, T. P., Clark, A. I., Amadi, A. A., & Coats, A. J. S. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00523-4 · Cited by 277
Ponikowski, P., Chua, T. P., Piepoli, M., Ondusova, D., Webb-Peploe, K., Harrington, D., Anker, S. D., Volterrani, M., Colombo, R., Mazzuero, G., et al. (1997) · Circulation · doi:10.1161/01.cir.96.8.2586 · Cited by 271
Faris, R., Flather, M., Purcell, H., Henein, M., Poole-Wilson, P., & Coats, A. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00600-3 · Cited by 260
Peacock, W. F., Costanzo, M. R., De Marco, T., Lopatin, M., Wynne, J., Mills, R. M., & Emerman, C. L. (2009) · Cardiology · doi:10.1159/000164149 · Cited by 262
Stein, B. C., & Levin, R. I. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70054-7 · Cited by 260
Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure
Luchner, A., Stevens, T. L., Borgeson, D. D., Redfield, M., Wei, C.-M., Porter, J. G., & Burnett, J. C. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.5.h1684 · Cited by 256
Voors, A. A., von Haehling, S., Anker, S. D., Hillege, H. L., Struck, J., Hartmann, O., Bergmann, A., Squire, I., van Veldhuisen, D. J., Dickstein, K., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp098 · Cited by 222
“SBP [mean (+SD)] 124 (17) 125 (16) 124 (17) 125 (14) 122 (21) 0.”
Colucci, W. S., Kolias, T. J., Adams, K. F., Armstrong, W. F., Ghali, J. K., Gottlieb, S. S., Greenberg, B., Klibaner, M. I., Kukin, M. L., & Sugg, J. E. (2007) · Circulation · doi:10.1161/circulationaha.106.666016 · Cited by 181
Curiati, J. A., Bocchi, E., Freire, J. O., Arantes, A. C., Braga, M., Garcia, Y., Guimarães, G., & Fo, W. J. (2005) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2005.11.465 · Cited by 119
Causes and treatment of oedema in patients with heart failure
Clark, A. L., & Cleland, J. G. F. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.191 · Cited by 112
Arginine Vasopressin Antagonists for the Treatment of Heart Failure and Hyponatremia
Finley, J. J., Konstam, M. A., & Udelson, J. E. (2008) · Circulation · doi:10.1161/circulationaha.108.765289 · Cited by 104
Pingitore, A., Iervasi, G., Barison, A., Prontera, C., Pratali, L., Emdin, M., Giannessi, D., & Neglia, D. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.05.009 · Cited by 67
The Potential Role of Renal Denervation in the Management of Heart Failure
Kassab, K., Soni, R., Kassier, A., & Fischell, T. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144147 · Cited by 19
Sherazi, S., Kutyifa, V., McNitt, S., Aktas, M. K., Couderc, J.-P., Peterson, B., Bloch Thomsen, P. E., Kautzner, J., Moss, A. J., & Zareba, W. (2015) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2015.03.004 · Cited by 13
Metadata
- Authors
- Francis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S.
- Venue
- Circulation
- Published
- 1990-11
- Volume
- 82
- Issue
- 5
- Pages
- 1724-1729
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2048664109
- Cited by
- 1,388
- References
- 11
- FWCI
- 22.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.